Utah Mounjaro Stomach Paralysis Lawsuit (2024 Update)

Quick Summary

• Suppose you or a loved one have experienced severe stomach paralysis after using Mounjaro in Utah. In that case, the Utah Mounjaro stomach paralysis lawsuit asserts that drug makers such as Eli Lilly failed to adequately warn about the serious gastrointestinal risks associated with this diabetes medication.
• This article will provide essential information about the lawsuit, potential legal actions you can take, and what to expect in terms of compensation and legal outcomes.
• If you or someone you care about has suffered complications from Mounjaro, Schmidt & Clark, LLP, is ready to help. With a strong reputation for plaintiff representation, our top priority is to secure the justice and compensation you deserve.

How S&C Can Help With Your Claim?

S&C can help with your claim by guiding you through the complexities of lawsuit claims. With our extensive experience in pharmaceutical litigation, particularly involving gastrointestinal medications, S&C Law Firm provides reliable support. We will assist in every phase of your legal journey, from investigating your claim to representing you in court.

At S&C, we understand the challenges you face and are committed to helping you navigate this difficult time. Here’s how we can help:

• Comprehensive Claim Investigation: We thoroughly investigate your claim, gathering all necessary evidence and documentation to build a strong case.
• Expert Legal Representation: Our experienced attorneys will represent you in court, ensuring that your voice is heard and your rights are protected.
• Personalized Support: We provide personalized support throughout the entire process, keeping you informed and involved every step of the way.

Mounjaro Stomach Paralysis Lawsuit

Numerous lawsuit claims have been filed against Eli Lilly, alleging that the company failed to adequately warn patients about the risk of stomach paralysis associated with their diabetes medication, Mounjaro.

To understand Mounjaro and its implications for those who have been taking it, we need to examine the drug’s intended use, its recall status, and the updated safety warnings that could influence diabetes treatment.

The lawsuit claims to accuse Eli Lilly of failing to inform patients about Mounjaro’s severe side effects, prioritizing profit over safety. Plaintiffs report abdominal pain, stomach paralysis, and emergency room visits, stating they were unaware of the severe gastrointestinal risks. They argue they would have avoided Mounjaro if properly warned about these dangers.

The lawsuits allege that Mounjaro’s labels downplayed the risks of gastroparesis and other severe complications therein. Many affected individuals trusted Eli Lilly to provide clear information about all risks but claimed the safety information was inadequate, leaving them vulnerable.

What Is Mounjaro?

According to Healthline, Mounjaro is a medication also known by its scientific name, tirzepatide. It is designed to help adults with type 2 diabetes manage their blood sugar levels [1].

Available in varying doses, Mounjaro works alongside diet and exercise by activating the body’s GIP and GLP-1 pathways to regulate blood sugar levels. This approach aims to meet the specific needs of individuals with this chronic condition.

Yet, Mounjaro is not a one-size-fits-all solution. It’s not recommended for those with type 1 diabetes or individuals under 18 years of age. Additionally, the safety of combining this drug with other GLP-1 receptor agonists remains uncertain.

While Mounjaro represents a significant advancement, it comes with considerations that users must carefully evaluate, particularly when thinking about using it alongside medications like Ozempic.

Was Mounjaro Recalled?

Mounjaro was not recalled in the wake of adverse reports. Despite the reported adverse events, Eli Lilly has not removed Mounjaro from the market. The FDA, while approving the drug for Type II diabetes, has not explicitly linked GLP-1 RA medications like Mounjaro to gastroparesis, leaving some questions unanswered.

According to the FDA, the concerns have not been ignored. The agency updated Mounjaro’s warning label to include a caution about the risk of intestinal blockage [2].

This update highlights the potential for serious gastrointestinal issues. For those affected, this acknowledgment is a positive step, offering legal leverage even without an official recall.

Patient safety is Lilly’s top priority, and we actively engage in monitoring, evaluating, and reporting safety information for all our medicines – Eli Lily and Co. told The Post in a statement.

Amidst growing concerns, Mounjaro’s label now bears new safety warnings highlighting the risk of intestinal blockages (ileus). In September 2023, the FDA updated the label to reflect these findings, marking a shift in the drug’s safety profile.

The revised label also warns about severe gastrointestinal diseases, including gastroparesis. This transparency informs users of the significant risks posed and underscores the importance of reporting safety information. While Ozempic’s label mentions bowel obstruction, Mounjaro’s warnings do not explicitly address gastroparesis.

Side Effects of Mounjaro

Mounjaro’s side effects aren’t to be taken lightly. For many, the drug’s promise for weight loss and blood sugar regulation has been overshadowed by a dark cloud of complications.

According to Mana, one such side effect is gastroparesis, or delayed gastric emptying, which can manifest as a result of using weight loss drugs like Mounjaro [3]:

• abdominal pain
• bloating
• nausea
• vomiting

These symptoms aren’t just uncomfortable-they can disrupt lives and lead to severe weight loss due to reduced nutrient absorption, which is often seen in nervous system diseases.

According to 2023 research by NIH, abdominal pain, often referred to as stomach pain, is a distress signal for 90% of those with gastroparesis, a testament to the severity of this condition. The side effects can spiral into a vortex of excessive vomiting and malnutrition, leaving some rushing to the emergency room multiple times [4].

Developing severe gastrointestinal issues is a condition that can erode the very quality of life, making every meal a gamble and every day a battle against the body’s rebellion.

How Do You Qualify for a Mounjaro Stomach Paralysis Lawsuit?

To qualify for a Mounjaro stomach paralysis lawsuit, you must have experienced severe side effects after using the drug. The first step is to prove a direct link between Mounjaro and your gastrointestinal issues, supported by medical documentation.

It’s not just about severe vomiting and stomach paralysis; any severe gastrointestinal problems that developed after using Mounjaro could be grounds for a lawsuit.

The Status Of The Mounjaro Lawsuit Litigation in Utah

In Utah, the legal landscape surrounding Mounjaro is changing quickly. The lawsuits have been combined into an MDL class action, creating a unified front against the pharmaceutical companies. As discussions continue and a ‘Science Day’ approaches, those affected by Mounjaro are hoping for clarity and justice.

The case is still developing, with both sides preparing to present medical and scientific evidence that could influence the outcome.

Recent reports emphasized some GLP-1 RA-associated risks of triggering depression and suicidal thoughts – Davide Arillotta, Researcher in Psychopharmacology at the Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire

Class Action vs. Individual Lawsuits

When deciding whether to join a class action lawsuit or file an individual lawsuit, it’s important to consider the benefits and drawbacks of each option. Class action lawsuits combine similar claims, offering the advantage of collective legal resources and shared costs.

This can be a more economical choice for those who may not have the resources to pursue an individual case. However, compensation in class action lawsuits is typically divided among all plaintiffs, which can result in lower individual settlements.

On the other hand, individual lawsuits provide more control over the case and the potential for compensation that more accurately reflects one’s specific injuries and losses.

While this path may be more challenging, the rewards can be greater, with settlements tailored to the individual’s unique circumstances. The decision should be made based on personal circumstances and the advice of a trusted attorney.

Mounjaro Lawsuit Settlement Amounts in Utah

For those involved in a Mounjaro lawsuit in Utah, understanding potential compensation is essential. Settlement amounts can vary significantly, typically ranging from $400,000 to $700,000.

Factors such as the duration of drug use, the severity of your condition, and the impact on your life all influence the final amount.

While these numbers can provide a general idea, remember that milder injuries often result in lower settlements compared to those caused by severe, lasting harm. Only an attorney, equipped with the specifics of your case and knowledge of the legal landscape, can provide an accurate estimate of what financial compensation might look like for you.

Filing a Mounjaro Stomach Paralysis Lawsuit in Utah

If you’re considering filing a lawsuit for stomach paralysis or other severe side effects from Mounjaro, know that the sands of time are slipping through the hourglass. With the statutes of limitations ticking away, it’s imperative to act swiftly and secure a legal partner who can navigate the complexities of your case.

Types of Evidence To Present

Building a solid foundation of evidence is crucial when preparing for a Mounjaro lawsuit.

Here’s what you need to gather:

1. Medical Records: Document your side effects and complications thoroughly.
2. Prescriptions: Keep detailed records of your Mounjaro use.
3. Additional Documentation: Gather any other relevant documents that can support your claim.

This isn’t just about collecting papers; it’s about crafting a narrative that connects your suffering to Mounjaro.

What is the Statute of Limitations for the Mounjaro Lawsuit in Utah?

The statute of limitations for the Mounjaro lawsuit in Utah is four years from the date the injury was discovered or should have been discovered. Time may heal wounds, but it can also close the window of opportunity for legal action.

This deadline isn’t just a suggestion-it’s a firm cutoff that, if missed, can extinguish your chances for compensation.

Related Articles:

• South Carolina Mounjaro Stomach Paralysis Lawsuit
• Virginia Mounjaro Stomach Paralysis Lawsuit
• Pennsylvania Mounjaro Stomach Paralysis Lawsuit

See all related dangerous drug lawsuits our attorneys covered so far.

Get Your Free Consultation From Our Utah Lawyers

The Schmidt & Clark, LLP law firm is dedicated to supporting you through these difficult times. If you or a loved one has experienced any severe gastrointestinal events or issues due to weight loss drugs like Mounjaro, reach out to us without delay.

Our experienced team specializes in handling such cases and will guide you through the legal process. We will clarify your rights and determine your eligibility for a lawsuit related to these complications.

Take advantage of our free case evaluation, and remember, we only charge fees if we win your case. Trust that our commitment to your case is as strong as if you were a member of our own family. Contact us today for a thorough review of your situation.

Reference:

1. https://www.healthline.com/health/drugs/mounjaro#_noHeaderPrefixedContent
2. https://www.fda.gov/drugs/drug-safety-and-availability/update-fdas-ongoing-evaluation-reports
3. https://mana.md/understanding-gastroparesis/
4. https://misuse.ncbi.nlm.nih.gov/error/abuse.shtml